SBI is a small biotech company that’s delivered innovative products and services for molecular and cell biology research since January 2004. SBI's focuses on being the first company to bring the newest methodologies to market—they were the first company to deliver exosome research reagents and CRISPR/Cas9 vectors—so researchers can quickly take advantage of the latest, most powerful approaches.

​

Dedicated to quality, many of SBI's products and service offerings are completed in their state-of-the-art facility in Palo Alto CA, enabling them to maintain control over manufacturing conditions and quality, ensure their service projects remain confidential, to deliver frequent and timely service project status updates.

​

SBI's experienced staff includes a high proportion of PhD-level scientists who interact directly with customers to provide product and services support. Their areas of expertise cover a range of offerings, including exosome research, genome engineering, cell biology, next-generation sequencing (NGS), qPCR microarrays, flow cytometry, and more.